申请人:Chugai Seiyaku Kabushiki Kaisha
公开号:US06673797B1
公开(公告)日:2004-01-06
There is provided a compound represented by the
general formula (1):
wherein Het represents an optionally substituted heterocyclic group; A1 and A2 each independently represent —CH═, etc.; A3 represents —CH2—, etc.; R1 represents a 4-fluorophenyl group, etc.; R2 represents an alkyl group; n represents 0, 1 or 2, provided that when A1 and A2 both are —CH═, A3 represents —CH2— or —SO2—, which is an indole derivative or a mono- or diazaindole derivative that has COX-2 inhibitory activity and is useful as a pharmaceutical, such as an anti-inflammatory agent, or addition salts thereof with a pharmaceutically acceptable acid or base, or hydrates thereof.
提供一种化合物,其一般式表示为(1):其中Het代表可选择地取代的杂环基团;A1和A2各自独立地表示—CH═等;A3表示—CH2—等;R1表示4-氟苯基团等;R2表示烷基团;n表示0、1或2,但当A1和A2都为—CH═时,A3表示—CH2—或—SO2—,它是一种COX-2抑制活性的吲哟衍生物或单或二氮杂吲哟衍生物,可用作药物,如抗炎药物,或其与药用可接受的酸或碱形成的加合盐,或其水合物。